Logo-jcvtr

J Cardiovasc Thorac Res. 2017;9(2): 71-77. doi: 10.15171/jcvtr.2017.12
PMID: 28740625        PMCID: PMC5516054

Original Article

Pulmonary valve replacement in patients with corrected tetralogy of Fallot

Fotios M. Mitropoulos 1, Meletios A. Kanakis 1, Christos Ntellos 2, Constantinos Loukas 3, Periklis Davlouros 4, Theophili Kousi 1, Andrew C. Chatzis 4 *

Cited by CrossRef: 12

1- Otsuka K, Kawano H, Ishimatsu T, Yoshimuta T, Doi Y, Fukae S, Koga S, Ikeda S, Eishi K, Maemura K. Successful management of heart failure 45 years after surgical correction of tetralogy of Fallot. Journal of Cardiology Cases. 2021;23(2):76 [Crossref]
2- Martens T, François K, De Wilde H, Campens L, Demulier L, De Backer J, Dewolf D, Bove T. QRS Duration During Follow-Up of Tetralogy of Fallot: How Valuable is it? Analysis of ECG Changes in Relation to Pulmonary Valve Implantation. Pediatr Cardiol. 2021;42(7):1488 [Crossref]
3- Agwu N, Recto M, Kheradvar A. Unmet Clinical Needs for Transcatheter Pulmonary Valves. Ann Biomed Eng. 2023;51(11):2384 [Crossref]
4- Fages T, Labombarda F, Maragnes P, Seita F, Hamon M. Usefulness of a New Transthoracic Echocardiography Score to Assess Right Ventricular Volumes in Patients with Repaired Tetralogy of Fallot. Pediatr Cardiol. 2022;43(1):171 [Crossref]
5- Hudaib M, Malik H, Rabbani S. Comment on: “Improved Outcomes After Pulmonary Valve Replacement in Repaired Tetralogy of Fallot”. Current Problems in Cardiology. 2023;48(10):101862 [Crossref]
6- Lueck S, Bormann E, Rellensmann K, Martens S, Rukosujew A. Impact of additional tricuspid valve annuloplasty in TOF patients undergoing pulmonary valve replacement. J Cardiovasc Surg. 2019;60(2) [Crossref]
7- Deshaies C, Trottier H, Khairy P, Al-Aklabi M, Beauchesne L, Bernier P, Dhillon S, Gandhi S, Haller C, Hancock Friesen C, Hickey E, Horne D, Jacques F, Kiess M, Perron J, Rodriguez M, Poirier N. Tricuspid Intervention Following Pulmonary Valve Replacement in Adults With Congenital Heart Disease. Journal of the American College of Cardiology. 2020;75(9):1033 [Crossref]
8- Siondalski P, Kołaczkowska M, Bieńkowski M, Pęksa R, Kowalik M, Dawidowska K, Vandendriessche K, Meuris B. Bacterial cellulose as a promising material for pulmonary valve prostheses: In vivo study in a sheep model. J Biomed Mater Res. 2024;112(1) [Crossref]
9- Wadia S, Lluri G, Aboulhosn J, Shivkumar K, Reemtsen B, Laks H, Biniwale R, Levi D, Salem M, Moore J. Ventricular arrhythmia burden after transcatheter versus surgical pulmonary valve replacement. Heart. 2018;104(21):1791 [Crossref]
10- Van Berendoncks A, Van Grootel R, McGhie J, van Kranenburg M, Menting M, Cuypers J, Bogers A, Witsenburg M, Roos‐Hesselink J, van den Bosch A. Echocardiographic parameters of severe pulmonary regurgitation after surgical repair of tetralogy of Fallot. Congenital Heart Disease. 2019;14(4):628 [Crossref]
11- Mongeon F, Ben Ali W, Khairy P, Bouhout I, Therrien J, Wald R, Dallaire F, Bernier P, Poirier N, Dore A, Silversides C, Marelli A. Pulmonary Valve Replacement for Pulmonary Regurgitation in Adults With Tetralogy of Fallot: A Meta-analysis—A Report for the Writing Committee of the 2019 Update of the Canadian Cardiovascular Society Guidelines for the Management of Adults With Congenital Heart Disease. Canadian Journal of Cardiology. 2019;35(12):1772 [Crossref]
12- Cleveland J, Wells W. The Surgical Approach to Pulmonary Valve Replacement. Seminars in Thoracic and Cardiovascular Surgery. 2022;34(4):1256 [Crossref]
13- Henning R. Diagnosis and treatment of adults with congenital heart disease. Future Cardiology. 2020;16(4):317 [Crossref]